vs

Side-by-side financial comparison of OMEGA HEALTHCARE INVESTORS INC (OHI) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

OMEGA HEALTHCARE INVESTORS INC is the larger business by last-quarter revenue ($323.0M vs $197.9M, roughly 1.6× REPLIGEN CORP). OMEGA HEALTHCARE INVESTORS INC runs the higher net margin — 49.1% vs 6.7%, a 42.4% gap on every dollar of revenue. On growth, OMEGA HEALTHCARE INVESTORS INC posted the faster year-over-year revenue change (16.7% vs 13.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 13.0%).

Omega Healthcare Investors Inc is a specialized real estate investment trust that owns, leases and manages healthcare-related real estate assets, mainly including skilled nursing facilities, senior housing and long-term care facilities across the U.S. and UK. It partners with healthcare operators to provide stable real estate support for quality patient care delivery.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

OHI vs RGEN — Head-to-Head

Bigger by revenue
OHI
OHI
1.6× larger
OHI
$323.0M
$197.9M
RGEN
Growing faster (revenue YoY)
OHI
OHI
+3.0% gap
OHI
16.7%
13.6%
RGEN
Higher net margin
OHI
OHI
42.4% more per $
OHI
49.1%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
13.0%
OHI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
OHI
OHI
RGEN
RGEN
Revenue
$323.0M
$197.9M
Net Profit
$158.6M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
49.1%
6.7%
Revenue YoY
16.7%
13.6%
Net Profit YoY
41.5%
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OHI
OHI
RGEN
RGEN
Q1 26
$323.0M
Q4 25
$319.2M
$197.9M
Q3 25
$311.6M
$188.8M
Q2 25
$282.5M
$182.4M
Q1 25
$276.8M
$169.2M
Q4 24
$279.3M
$174.1M
Q3 24
$276.0M
$154.9M
Q2 24
$252.7M
$154.1M
Net Profit
OHI
OHI
RGEN
RGEN
Q1 26
$158.6M
Q4 25
$172.0M
$13.3M
Q3 25
$179.7M
$14.9M
Q2 25
$136.6M
$14.9M
Q1 25
$109.0M
$5.8M
Q4 24
$116.5M
$-30.3M
Q3 24
$111.8M
$-654.0K
Q2 24
$113.9M
$3.3M
Gross Margin
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
53.7%
9.0%
Q3 25
61.4%
8.9%
Q2 25
52.1%
7.6%
Q1 25
41.4%
3.9%
Q4 24
42.5%
-17.7%
Q3 24
40.3%
-5.1%
Q2 24
47.1%
1.0%
Net Margin
OHI
OHI
RGEN
RGEN
Q1 26
49.1%
Q4 25
53.9%
6.7%
Q3 25
57.7%
7.9%
Q2 25
48.4%
8.2%
Q1 25
39.4%
3.4%
Q4 24
41.7%
-17.4%
Q3 24
40.5%
-0.4%
Q2 24
45.1%
2.2%
EPS (diluted)
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
$0.56
$0.24
Q3 25
$0.59
$0.26
Q2 25
$0.46
$0.26
Q1 25
$0.33
$0.10
Q4 24
$0.41
$-0.55
Q3 24
$0.42
$-0.01
Q2 24
$0.45
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OHI
OHI
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$26.1M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$5.2B
$2.1B
Total Assets
$10.2B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OHI
OHI
RGEN
RGEN
Q1 26
$26.1M
Q4 25
$27.0M
$767.6M
Q3 25
$737.2M
$748.7M
Q2 25
$734.2M
$708.9M
Q1 25
$368.0M
$697.2M
Q4 24
$518.3M
$757.4M
Q3 24
$342.4M
$784.0M
Q2 24
$35.2M
$809.1M
Total Debt
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
$4.3B
$542.2M
Q3 25
$5.0B
$537.9M
Q2 25
$5.0B
Q1 25
$4.4B
Q4 24
$4.8B
$525.6M
Q3 24
$4.9B
Q2 24
$4.7B
Stockholders' Equity
OHI
OHI
RGEN
RGEN
Q1 26
$5.2B
Q4 25
$5.2B
$2.1B
Q3 25
$5.0B
$2.1B
Q2 25
$5.0B
$2.1B
Q1 25
$4.7B
$2.0B
Q4 24
$4.5B
$2.0B
Q3 24
$4.2B
$2.0B
Q2 24
$3.7B
$2.0B
Total Assets
OHI
OHI
RGEN
RGEN
Q1 26
$10.2B
Q4 25
$10.0B
$2.9B
Q3 25
$10.6B
$2.9B
Q2 25
$10.5B
$2.9B
Q1 25
$9.7B
$2.9B
Q4 24
$9.9B
$2.8B
Q3 24
$9.6B
$2.8B
Q2 24
$8.8B
$2.9B
Debt / Equity
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
0.82×
0.26×
Q3 25
0.99×
0.26×
Q2 25
1.00×
Q1 25
0.94×
Q4 24
1.07×
0.27×
Q3 24
1.15×
Q2 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OHI
OHI
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
$878.6M
$25.7M
Q3 25
$226.7M
$48.1M
Q2 25
$239.3M
$28.6M
Q1 25
$182.0M
$15.0M
Q4 24
$749.4M
$39.2M
Q3 24
$184.9M
$49.3M
Q2 24
$184.1M
$42.2M
Free Cash Flow
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
$797.7M
$17.6M
Q3 25
$205.5M
$43.4M
Q2 25
$226.5M
$21.5M
Q1 25
$161.8M
$11.4M
Q4 24
$711.7M
$33.6M
Q3 24
$176.6M
$42.3M
Q2 24
$177.0M
$37.4M
FCF Margin
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
249.9%
8.9%
Q3 25
65.9%
23.0%
Q2 25
80.2%
11.8%
Q1 25
58.4%
6.8%
Q4 24
254.8%
19.3%
Q3 24
64.0%
27.3%
Q2 24
70.0%
24.3%
Capex Intensity
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
25.3%
4.1%
Q3 25
6.8%
2.5%
Q2 25
4.5%
3.9%
Q1 25
7.3%
2.1%
Q4 24
13.5%
3.2%
Q3 24
3.0%
4.5%
Q2 24
2.8%
3.1%
Cash Conversion
OHI
OHI
RGEN
RGEN
Q1 26
Q4 25
5.11×
1.93×
Q3 25
1.26×
3.23×
Q2 25
1.75×
1.92×
Q1 25
1.67×
2.57×
Q4 24
6.43×
Q3 24
1.65×
Q2 24
1.62×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OHI
OHI

Rental income$266.9M83%
Other$45.2M14%
Resident fees and services$6.7M2%
Real estate tax and ground lease income$3.8M1%
Miscellaneous income$526.0K0%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons